Product
Rhopressa®
1 clinical trial
2 indications
Indication
GlaucomaIndication
ocular hypertensionClinical trial
Efficacy and Safety Assessment of T4090 Ophthalmic Solution (Preservative-free Kinezodianone R HCl 0.2% or 0.3%) Versus Rhopressa® Ophthalmic Solution (Preserved Netarsudil 0.02%) in Patients With Open-angle Glaucoma or Ocular HypertensionStatus: Not yet recruiting, Estimated PCD: 2025-05-01